Ahngook wins lawsuit over amlodipine
Published: 2008-02-19 07:00:00
Updated: 2008-02-19 07:00:00
Ahngook Pharm has won the right to market its antihypertensive agent, Levotension (amlopipine besylate S), as the Seoul High Court made its ruling on February 12 that Pfizer's amlodipine patent is null and void, upholding a lower court's ruling on May 11, 2007.
Levotension is known as a S-isom...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
